Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: CYBERKEN who wrote (1690)	2/11/2001 9:01:29 PM
From: Torben Noerup Nielsen	Respond to of 3202

I see no basis for saying that it will take 10 years for gene-to-drug. Maybe that would be true based on present rates. But that's just the tangent on a curve that is probably exponential. I would assume that getting past the FDA will take about the same time it is taking now. Although even a few years could easily see changes in that process. One shouldn't forget that much of the genetic information that is being used to develop new drugs has been known for some time. The official publiciation of the genome is a non-event as far as real work is concerned.